Company Encyclopedia
View More
name
West Pharmaceutical
WST.US
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products.
770.89 B
WST.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
B
Life Sciences Tools and ServicesIndustry
Industry Ranking5/60
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE16.94%A
    • Profit Margin16.29%A
    • Gross Margin36.58%C
  • Growth ScoreC
    • Revenue YoY4.92%C
    • Net Profit YoY-1.58%C
    • Total Assets YoY11.72%B
    • Net Assets YoY10.88%B
  • Cash ScoreC
    • Cash Flow Margin613.77%C
    • OCF YoY4.92%C
  • Operating ScoreB
    • Turnover0.78B
  • Debt ScoreB
    • Gearing Ratio25.68%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    West Pharmaceutical Services Inc. Stock Underperforms Monday When Compared To Competitors

    West Pharmaceutical Services Inc. stock fell 1.12% to $274.14 on Monday, underperforming compared to competitors. The S&P 500 and Dow Jones also declined. West Pharmaceutical is 21.43% below its 52-week high. Competitors Abbott Laboratories and Becton Dickinson & Co. also fell, while Baxter International Inc. rose. Trading volume was below average.

    Dow Jones·
    US
    WST
    -0.55%
    Dow Jones·
    US
    WST
    -0.55%

    Pharmaceutical Technology Excellence Awards 2025: West Pharmaceutical Services

    West Pharmaceutical Services won the Product Launches award in the Prefillable Syringe Systems category at the 2025 Pharmaceutical Technology Excellence Awards for their West Synchrony™ prefillable syringe system. This system integrates syringe components into a single, data-driven platform, enhancing development efficiency and supply reliability for biologics and vaccines. The award highlights West's shift from component supply to a fully verified system-level platform, reducing complexity and regulatory risks for pharmaceutical companies.

    Pharmaceutical Technology·
    US
    WST
    -0.55%
    Pharmaceutical Technology·
    US
    WST
    -0.55%

    Morgan Stanley Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

    Morgan Stanley's stock rose 1.52% to $167.94 on Wednesday, marking its third consecutive day of gains. Despite this, it underperformed compared to competitors like JPMorgan Chase, Wells Fargo, and Charles Schwab. The stock is 2.23% below its 52-week high. Trading volume was 1 million below the 50-day average.

    Dow Jones·
    US
    MS
    +0.93%
    Dow Jones·
    US
    MS
    +0.93%

    West Pharmaceutical Services Inc. Stock Rises Monday, Still Underperforms Market

    West Pharmaceutical Services Inc. (WST) stock rose 1.08% to $273.99 on Monday, despite underperforming the market. The S&P 500 Index increased by 1.55% and the Dow Jones Industrial Average by 0.44%. This marks the second consecutive day of gains for WST, which remains 21.47% below its 52-week high. Competitors Abbott Laboratories, Becton Dickinson & Co., and Baxter International Inc. saw declines. Trading volume was higher than the 50-day average.

    Dow Jones·
    US
    WST
    -0.55%
    Dow Jones·
    US
    WST
    -0.55%

    Stevens Capital Management LP Acquires Shares of 1,232 West Pharmaceutical Services, Inc. $WST

    Stevens Capital Management LP acquired 1,232 shares of West Pharmaceutical Services, Inc. (NYSE:WST) valued at approximately $270,000 during the second quarter. Several other institutional investors also adjusted their positions in WST. Analysts have mixed ratings on WST, with a consensus price target of $349.20. WST reported Q3 earnings of $1.96 per share, beating estimates, with revenue of $804.60 million. The company has a market cap of $19.50 billion and a P/E ratio of 40.15.

    Market Beat·
    US
    WST
    -0.55%
    Market Beat·
    US
    WST
    -0.55%
    © 2025 Longbridge｜Disclaimer